GELLI MOR DCA LTD

Company number 13106756 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

GELLI MOR DCA LTD - Analysis Report

Company Number: 13106756

Analysis Date: 2025-07-20 12:22 UTC

Financial Health Assessment of GELLI MOR DCA LTD (As at 31 December 2023)


1. Financial Health Score: C

Explanation:
The company shows signs of recovery from previous financial distress but remains in a fragile state. The positive turnaround in net current assets and net assets is encouraging ("signs of convalescence"), yet the relatively low net equity and high liabilities indicate ongoing vulnerability. This grade reflects a moderate health status with potential risks that require careful management.


2. Key Vital Signs

Metric 2023 Value Interpretation
Current Assets £184,203 Healthy increase, largely due to increased cash and debtors.
Cash at Bank £125,154 Strong liquidity position—positive "pulse" indicating cash availability.
Debtors £59,049 Higher receivables, which may signal more business but requires monitoring for timely collection.
Current Liabilities £109,637 Substantially reduced from prior years, easing short-term pressure.
Net Current Assets £74,566 Positive working capital ("healthy blood pressure"), showing ability to meet short-term obligations.
Total Assets less Current Liabilities £349,081 Increased asset base after covering current debts, a positive sign.
Long-Term Liabilities £342,805 High level of secured debt, a "chronic condition" that could impair financial flexibility.
Net Assets (Equity) £1,388 Slightly positive equity after years of deficits, indicating recovery but still very thin capital buffer.
Share Capital £2 Nominal capital; company relies mostly on reserves and external financing.
Employment Numbers 18 employees Growing workforce, indicating operational expansion.
Tax Liabilities £62,717 (current year) Significant tax payments may affect cash flow ("tax burden symptom").

3. Diagnosis

Symptoms Analysis:

  • Recovery from Distress: The company has demonstrated financial "healing" compared to previous years, moving from negative net assets of over £40,000 in 2022 to a small positive net asset position in 2023. This suggests operational improvements or asset revaluation.

  • Liquidity Improvement: Cash reserves have increased markedly, providing a "healthy pulse" and reducing the risk of immediate cash flow crises.

  • High Leverage: Despite improved liquidity, the company carries a substantial long-term debt burden (£342,805), secured against assets, which represents a "chronic illness" that could constrain growth and flexibility.

  • Working Capital: Positive net current assets demonstrate that the company can cover its short-term liabilities from current assets, a crucial indicator of financial health ("stable heartbeat").

  • Modest Equity Base: Shareholders' funds remain very low, indicating limited "immune system" strength to absorb shocks or losses.

  • Operational Growth Indicated: Increasing employee headcount and rising debtors suggest business expansion but also potential risks if receivables are not collected promptly.

Overall Diagnosis:
The company has moved from a state of financial distress to a cautiously stable position, with improved liquidity and working capital. However, the high level of secured debt and thin equity base imply vulnerability to adverse events or downturns. Continued operational growth needs to be managed carefully to avoid relapse.


4. Recommendations

  1. Debt Management:

    • Negotiate with lenders to manage or restructure long-term debt to reduce interest costs and improve cash flow flexibility.
    • Explore refinancing options to lower debt servicing burden ("alleviate chronic symptoms").
  2. Strengthen Equity Base:

    • Consider capital injection from shareholders or reinvestment of profits to build a stronger equity buffer ("boost immune response").
    • Limit dividend payments until equity position is more robust.
  3. Improve Receivables Collection:

    • Implement tighter credit control and faster collection processes to convert debtors into cash more quickly ("optimise blood flow").
  4. Cash Flow Monitoring:

    • Maintain close monitoring of cash flows, especially given significant tax payments.
    • Build a cash reserve cushion to handle unexpected expenses.
  5. Operational Efficiency:

    • Review cost structures and productivity given increased staffing, ensuring that growth is sustainable and profitable.
  6. Regular Financial Reviews:

    • Continue frequent financial health checks to detect early warning signs of distress and respond promptly.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.